Google and Flo Push Cycle Data Into a Bigger Health Ecosystem

Menstrual health data is moving into a much larger health conversation. Google and Flo Health are joining forces to connect cycle tracking with broader wellness tools, while Clue is building a direct route from app data to women’s healthcare services.

The shift brings new opportunities, but it also puts permission and privacy at the center. For people who track symptoms, fertility, sleep, activity, or recovery, these partnerships could turn separate pieces of information into a more complete picture of health.

Flo Data Is Coming to Google Health

Flo Health users will be able to sync their cycle data with the Google Health app starting early next year. Google announced its partnership with Flo Health to bring more comprehensive menstrual health data into the app and use those insights to build future products together, including wellness hardware.

The partnership connects Flo’s menstrual health tracking with Google’s wider health platform. Flo data will also be available to the Google Health Coach for people who subscribe to Google Health Premium, adding cycle information to the data available through that service.

Google says the connection will remain under the user’s control. “No data will move between the apps without your explicit permission — given separately for each type of data and each purpose — and you have the control to withdraw permission at any time,” Google said.

Flo data will not be used for advertising, and it will not be sold or shared with other apps or developers. That promise matters because menstrual and fertility information can reveal deeply personal details about someone’s health, routines, and life stages.

Google described a broader goal for the partnership: “Connecting the dots across sleep, daily readiness, activity, and recovery gives a clearer picture of your overall health across the different phases of your cycle and stages of life.” The idea is to place cycle data alongside other health signals instead of treating it as a separate category.

Flo Users Also Face a Settlement Deadline

The partnership arrives alongside a legal payout opportunity for some Flo fertility app users. People who used the app between Nov. 1, 2016 and Feb. 28, 2019, are entitled to a payout from a $59.5 million settlement.

The sign-up window for the settlement is open until Oct. 15. Payments will depend on the total number of claimants, so the amount each eligible person receives is tied to how many people submit claims.

That deadline creates a clear task for eligible users who used Flo during the stated period: submit a claim before Oct. 15. The settlement and the new Google partnership sit next to each other in the same expanding health-data landscape, where users want useful services but also need clear rules about how their information moves.

Clue Connects Tracking With Care

Clue is taking a different step by moving beyond tracking and into healthcare access. The women-led period and cycle tracking app announced Get Care, a service that connects users directly to care across various women’s health areas from within the app.

Get Care includes partnerships with TwentyEight Health, Evaro, TeleClinic, inne, Plan Your Baby, Hertility, Embla, Navicare, and Novo Nordisk. Together, the partners cover a wide set of needs:

• Evaro and inne provide contraception options, while Evaro also supports perimenopause care.
• Plan Your Baby focuses on fertility and conception.
• Hertility offers at-home hormone and fertility testing.
• Embla supports weight and metabolic health.
• Navicare provides mental health support.
• Novo Nordisk works across metabolic health and women’s health.
• TwentyEight Health and TeleClinic are also part of the Get Care network for women’s health services.

Clue says more than 100 million people across 190 countries use the app, and users have opted in to track more than 250 million cycles. The company, BioWink GmbH, also works with research institutions including MIT, Oxford, and Columbia.

That scale gives Clue a large base of health experiences to connect with care options. In a survey of 12,000 Clue users, two-thirds reported concerns about their menstrual health, while nearly one in four new Clue users said gathering symptoms to share with a healthcare provider was a key reason they joined the app.

“Women are already using their Clue data to navigate the healthcare system and advocate for the care they need. But women should not have to do all the work of connecting what they know about their bodies with the care available to them. Get Care is about making that next step easier, giving women trusted options and a clearer path to the right care. Every partner is vetted, and the decision is always the user’s to make,” said Rhiannon White, CEO at Clue.

Novo Nordisk also framed the partnership around access to dependable health information. “Supporting women in understanding and managing their health, with reliable information, is at the heart of our mission at Novo,” said Kathrine Bengaard Poulsen, Senior Vice President, Medical, Marketing & Regulatory, International Operations at Novo Nordisk.

A New Phase for Personal Health Apps

Google, Flo, and Clue are showing how cycle apps can become gateways to broader health services. One path links menstrual data with sleep, readiness, activity, recovery, and future hardware; another connects tracked symptoms with care, testing, and treatment options.

The next stage will depend on trust. Users will need clear permissions, control over their data, and confidence that partnerships deliver useful care without turning sensitive health information into an advertising product. With Flo’s Google Health connection planned for early next year and Clue’s Get Care network now spanning multiple health areas, the role of cycle tracking is expanding fast.

Stay connected via Google News

Follow us for the latest AI News